This may explain our finding that apilimod, but not siPIKfyve, increased viral RNA replication and why apilimod and two other PIKfyve inhibitors could not clear the virus or protect mice from SARS-CoV-2 infection60. This evidence concerns the gene PIKFYVE and COVID-19.